newsfilter
← Latest News
GlobeNewswire·

Vivani Medical Announces Participation in Upcoming Investor Conferences

  • Vivani Medical (NASDAQ: VANI) announced participation in the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference on September 10, 2026, at the Metropolitan Club in New York.
  • The company will attend the H.C. Wainwright 28th Annual Global Investment Conference from September 14-16, 2026, at the Lotte New York Palace Hotel in New York.
  • A pre-recorded presentation for the H.C. Wainwright conference will be available starting at 7 a.m. Eastern Time on September 11, 2026, via a provided link.
  • Vivani utilizes its proprietary NanoPortal™ technology to develop miniature, ultra long-acting drug implants designed for once- or twice-yearly administration.
  • The company is developing a portfolio of GLP-1 based implants targeting metabolic diseases such as obesity & type 2 diabetes.
  • These implants aim to address medication non-adherence, which affects approximately 50% of patients, by avoiding challenges associated with daily or weekly oral & injectable treatments.